A phase I trial of OPNT-002 for the treatment of alcohol use disorder

Trial Profile

A phase I trial of OPNT-002 for the treatment of alcohol use disorder

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Jul 2017

At a glance

  • Drugs OPNT 002 (Primary)
  • Indications Alcoholism
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jul 2017 Results published in an Opiant Pharmaceuticals Media Release.
    • 19 Jul 2017 According to an Opiant Pharmaceuticals media release, This study was conducted under a clinical trial agreement between Opiant and the National Institute of Drug Abuse (NIDA), a division of the National Institutes of Health (NIH).
    • 07 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top